Eyenuk, Inc.
@eyenukinc
Advanced automated retinal image analysis including A.I. based Diabetic Retinopathy and macular degeneration eye screening.
ID: 842392112
https://www.eyenuk.com 23-09-2012 20:56:19
422 Tweet
270 Followers
219 Following
Eyenuk, Inc. Founder and CEO Kaushal Solanki featured in LifeSciences Intelligence article discussing the use of AI in the care of diabetic retinopathy. ow.ly/c03B50L8hvE
Eyenuk, Inc. secures $26 Million Series A funding to accelerate global access to AI-powered eye screening technology. ow.ly/Syfo50LbMtT @AXAIMAlts
.Eyenuk, Inc. announces it has secured $26 million in a Series A financing round, bringing the company’s total funding to over $43 million. bit.ly/3sap5vw
Eyenuk, Inc. is proud to announce we are selected from hundreds of competing companies as a Rising Star Finalist for a @ucsfhealthaward! Join us for a conversation with the finalists, Thursday 10/27 at 11 am PT on Zoom. Registration link: bit.ly/3ChMfVx #DHA2022
Check out the latest edition of Retinal Physician magazine, where the #EyeArt system is featured in a cover story titled "Artificial Intelligence for the Screening of Diabetic Retinopathy." ow.ly/vPNV50LrVgq #ai #medtech #diabetescare
Visit Eyenuk, Inc. this week to learn more about our #EyeArt #AI system for #diabeticretinopathy testing. You can find us in Booth 426 at the NAMCP Fall Managed Care Forum in Las Vegas, NV and Booth 116 at The TheRetinaSociety meeting in Pasadena, CA.
On World Diabetes Day, Eyenuk, Inc. recognizes Endocrine Associates of West Village for launching the EyeArt AI system for diabetic retinopathy screening. This implementation marks the first endocrinology practice in New York to adopt autonomous AI for diabetic eye testing.
This is where Retina Global comes in, which has supported AI development with multiple companies, managed validation studies, and provides the last mile benefit to patients, including in partnership with Eyenuk, Inc., Inc. in its OrangeCounty EyeProject.
Read this story to learn how NIH-funded Eyenuk, Inc. uses #AI to prevent blindness in people with diabetes. #SBIR #NationalDiabetesMonth ow.ly/ylwW50LGst4 California Life Sciences (CLS) @BiocomCA NEI
BREAKING NEWS: Eyenuk, Inc. has been approved to market its EyeArt AI eye screening system in the European Union for the new uses of detecting AMD and glaucomatous optic nerve damage. #Ophthalmology #AMD #Glaucoma ophthalmologytimes.com/view/eyenuk-ge…
Eyenuk, Inc. Secures the First European Union #MDR Certification for Autonomous #AI Detection of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma. ow.ly/rFTC50MFwXy #artificialintelligence #digitalhealth #ophthalmology
Eyenuk received FDA clearance to use an additional retinal camera for the detection of diabetic retinopathy (DR) that is easier to use and make it easier for primary care clinics to adopt the technology. Read More: ow.ly/b0Fh50OULph Eyenuk, Inc.
